454 related articles for article (PubMed ID: 19741458)
1. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation.
Teramura Y; Iwata H
Transplantation; 2009 Sep; 88(5):624-30. PubMed ID: 19741458
[TBL] [Abstract][Full Text] [Related]
2. Improvement of graft survival by surface modification with poly(ethylene glycol)-lipid and urokinase in intraportal islet transplantation.
Teramura Y; Iwata H
Transplantation; 2011 Feb; 91(3):271-8. PubMed ID: 21344734
[TBL] [Abstract][Full Text] [Related]
3. Islets surface modification prevents blood-mediated inflammatory responses.
Teramura Y; Iwata H
Bioconjug Chem; 2008 Jul; 19(7):1389-95. PubMed ID: 18533707
[TBL] [Abstract][Full Text] [Related]
4. Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation.
Xie D; Smyth CA; Eckstein C; Bilbao G; Mays J; Eckhoff DE; Contreras JL
Biomaterials; 2005 Feb; 26(4):403-12. PubMed ID: 15275814
[TBL] [Abstract][Full Text] [Related]
5. Effect of glucose toxicity on intraportal tilapia islet xenotransplantation in nude mice.
Al-Jazaeri A; Xu BY; Yang H; Macneil D; Leventhal JR; Wright JR
Xenotransplantation; 2005 May; 12(3):189-96. PubMed ID: 15807769
[TBL] [Abstract][Full Text] [Related]
6. Immobilization of soluble complement receptor 1 on islets.
Luan NM; Teramura Y; Iwata H
Biomaterials; 2011 Jul; 32(20):4539-45. PubMed ID: 21459435
[TBL] [Abstract][Full Text] [Related]
7. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation.
Cabric S; Sanchez J; Lundgren T; Foss A; Felldin M; Källen R; Salmela K; Tibell A; Tufveson G; Larsson R; Korsgren O; Nilsson B
Diabetes; 2007 Aug; 56(8):2008-15. PubMed ID: 17540953
[TBL] [Abstract][Full Text] [Related]
8. Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid.
Chen H; Teramura Y; Iwata H
J Control Release; 2011 Mar; 150(2):229-34. PubMed ID: 21108976
[TBL] [Abstract][Full Text] [Related]
9. Islet surface modification with urokinase through DNA hybridization.
Takemoto N; Teramura Y; Iwata H
Bioconjug Chem; 2011 Apr; 22(4):673-8. PubMed ID: 21425812
[TBL] [Abstract][Full Text] [Related]
10. A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets.
Contreras JL; Xie D; Mays J; Smyth CA; Eckstein C; Rahemtulla FG; Young CJ; Anthony Thompson J; Bilbao G; Curiel DT; Eckhoff DE
Surgery; 2004 Sep; 136(3):537-47. PubMed ID: 15349100
[TBL] [Abstract][Full Text] [Related]
11. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
[TBL] [Abstract][Full Text] [Related]
12. Inosine improves islet xenograft survival in immunocompetent diabetic mice.
Schneider S; Klein HH
Eur J Med Res; 2005 Jul; 10(7):283-6. PubMed ID: 16055398
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of instant blood-mediated inflammatory responses by co-immobilization of sCR1 and heparin on islets.
Luan NM; Iwata H
Biomaterials; 2013 Jul; 34(21):5019-24. PubMed ID: 23578554
[TBL] [Abstract][Full Text] [Related]
14. The influence of immune system stimulation on encapsulated islet graft survival.
Orłowski TM; Godlewska E; Tarchalska M; Kinasiewicz J; Antosiak M; Sabat M
Arch Immunol Ther Exp (Warsz); 2005; 53(2):180-4. PubMed ID: 15928588
[TBL] [Abstract][Full Text] [Related]
15. Influence of hepatocyte-rich liver cell mixture and liver fibroblasts on prolonging graft islet survival in rats without immunosuppressive drugs.
Soto-Montenegro L; Zugasti-Murillo A; Rollán E; Alvarez Y; Alvarez G; Jara-Albarrán A
Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):580-6. PubMed ID: 15578333
[TBL] [Abstract][Full Text] [Related]
16. Cell Surface Engineering for Regulation of Immune Reactions in Cell Therapy.
Teramura Y; Asif S; Ekdahl KN; Nilsson B
Adv Exp Med Biol; 2015; 865():189-209. PubMed ID: 26306451
[TBL] [Abstract][Full Text] [Related]
17. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
18. Small islets are essential for successful intraportal transplantation in a diabetes mouse model.
Su Z; Xia J; Shao W; Cui Y; Tai S; Ekberg H; Corbascio M; Chen J; Qi Z
Scand J Immunol; 2010 Dec; 72(6):504-10. PubMed ID: 21044124
[TBL] [Abstract][Full Text] [Related]
19. Continuous, but not occasional, oral ethanol intake reduces the success of intraportal transplanted islets of Langerhans: an experimental study.
Liu X; Matsumoto S; Noguchi H; Yonekawa Y; Iwanaga Y; Okitsu T; Nagata H; Miyakawa S; Song C; Jackson A; Naziruddin B; Levy MF
Transplant Proc; 2008 Mar; 40(2):441-3. PubMed ID: 18374095
[TBL] [Abstract][Full Text] [Related]
20. Microencapsulation of cells, including islets, within stable ultra-thin membranes of maleimide-conjugated PEG-lipid with multifunctional crosslinkers.
Teramura Y; Oommen OP; Olerud J; Hilborn J; Nilsson B
Biomaterials; 2013 Apr; 34(11):2683-93. PubMed ID: 23347835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
